Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Bone Oncology|January 14, 2025
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMSFrancesco Bertoldo, Cristina Eller-Vainicher, Vittorio Fusco, et al.
Biomedicines|October 21, 2020
Development of a Multifunctional Bioerodible Nanocomposite Containing Metronidazole and Curcumin to Apply on L-PRF Clot to Promote Tissue Regeneration in DentistryDenise Murgia, Giuseppe Angellotti, Alice Conigliaro, et al.
Journal of Clinical Medicine|September 23, 2022
Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case SeriesOlga Di Fede, Carmine Del Gaizo, Vera Panzarella, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 16, 2022
The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienistsRodolfo Mauceri, Rita Coniglio, Antonia Abbinante, et al.
Frontiers in Oral Health|November 17, 2025
Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory studyRodolfo Mauceri, Martina Coppini, Sara Maria Marchese, et al.
International Journal of Environmental Research and Public Health|August 27, 2021
The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined ProtocolsOlga Di Fede, Federica Canepa, Vera Panzarella, et al.
Frontiers in Oral Health|June 27, 2025
Oral squamous cell carcinoma vs. medication-related osteonecrosis of the jaw in patients assuming bone-modifying agents: a diagnostic challenge in a multi-hospital case seriesRodolfo Mauceri, Martina Coppini, Gaetano La Mantia, et al.
Biomed Research International|September 14, 2018
Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal StudyRodolfo Mauceri, Vera Panzarella, Laura Maniscalco, et al.
Oral Diseases|February 6, 2024
Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ)Alberto Bedogni, Rodolfo Mauceri, Vittorio Fusco, et al.
BMC Oral Health|February 4, 2023
MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case seriesRodolfo Mauceri, Martina Coppini, Massimo Attanasio, et al.
Pageof 6